“Lower Undercarboxylated Osteocalcin Linked to Insulin Resistance and Impaired Beta-Cell Function in Type 2 Diabetes: Implications for Bone Health and Metabolic Regulation” (As a single title for the text while still conveying the main points, I had to expand it from the original text.)

https://pubmed.ncbi.nlm.nih.gov/38115864

This study suggests that lower levels of undercarboxylated osteocalcin, a bone-related biomarker, are associated with insulin resistance and poorer beta-cell function in people with Type 2 diabetes, indicating a potential link between bone health and metabolic regulation.